| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression. | Clin Cancer Res | 2012 | 1.01 |
| 2 | Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients. | Oncotarget | 2014 | 0.89 |
| 3 | Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases. | PLoS One | 2012 | 0.78 |